Growth of Keloid-Producing Fibroblasts in Commercially Available Serum-Free Media

Abstract

The purpose of this study was to update our in vitro serum-free keloid fibroblast (KF) model by use of commercially available media. Prior evaluations of fibroblast characteristics in vitro, especially that of growth factor measurement, have been confounded by the presence of serum-containing media. KFs were obtained from patients undergoing facial keloid removal. The 4 commercially available serum-free media evaluated were AIM-V (Gibco, Grand Island, NY), Fibroblast Growth Medium (FGM; Clonetics, San Diego, CA), HB GRO (Irvine Scientific, Santa Ana, CA), and UltraCULTURE (BioWhittaker Inc, Walkersville, MD). The main outcome measures were sustained KF growth and viability as compared with serum-based models. The KFs in UltraCULTURE had a higher viability but did not grow as well as in FGM. The KFs in HB GRO and AIM-V demonstrated significantly decreased viability. Because of FGM's satisfactory proliferative support and viability comparable with serum-based medium, it is recommended for the in vitro propagation of keloid-producing fibroblasts.

Get full access to this article

View all access options for this article.

References

Koch

Goode

Simpson

Serum-free keloid fibroblast cell culture: An in vitro model for the study of aberrant wound healing. Plast Reconstr Surg 1997;99:1094–8.

Datubo-Brown

Keloids: A Review of the literature. Br J Plast Surg 1990;43:70–7.

Russell

Trupin

Rodriguez-Eaton

, et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988;85:587–91.

Lawrence

In search of the optimal treatment of keloids: Report of a series and a Review of the literature. Ann Plast Surg 1992;27:164–78.

Peltonen

Hsiao

Sirkku

, et al. Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J Invest Dermatol 1991;97:240–8.

Younai

Venters

, et al. Role of growth factors in scar contraction: An in vitro analysis. Ann Plast Surg 1996;36:495–501.

Younai

Nichter

Wellisz

, et al. Modulation of collagen synthesis by transforming growth factor-β in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994;33:148–51.

Tan

Rouda

Greenbaum

, et al. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am J Pathol 1993;142:463–70.

Cruz

Korchin

Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 1994;33:401–5.

10.

Berman

Flores

Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997;37:755–7.

11.

Yamada

Tajima

Nishikawa

, et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem 1994;116:892–7.

12.

Nakajima

Kishi

Tsuchiya

, et al. Exposure of fibroblasts derived from keloid patients to low-energy electromagnetic fields: Preferential inhibition of cell proliferation, collagen synthesis, and transforming growth factor beta expression in keloid fibroblasts in vitro. Ann Plast Surg 1997;39:536–41.